d-alpha tocopherol has been researched along with haloperidol in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Althaus, JS; Burian, MA; VonVoigtlander, PF; Williams, LR | 1 |
| Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK | 1 |
| Kadysheva, NM; Kryzhanovskiĭ, GN; Mokhovikov, AN; Mosketi, KV | 1 |
| Borisenko, SA; Burov, IuV | 1 |
| Behrens, S; Emrich, A; Gattaz, WF | 1 |
| Behl, C; Holsboer, F; Rupprecht, R; Skutella, T | 1 |
| Behl, C; Holsboer, F; Post, A | 1 |
| Eranti, VS; Gangadhar, BN; Janakiramaiah, N | 1 |
| Behl, C | 1 |
| Galili, R; Gil-Ad, I; Melamed, E; Offen, D; Weizman, A | 1 |
| Almeida, OF; Holsboer, F; Michaelidis, TM; Ohl, F; Post, A; Rücker, M; Uhr, M | 1 |
| Bhattacharya, D; Bhattacharya, SK; Ghosal, S; Sairam, K | 1 |
| Bhattachary, SK; Bhattacharya, D; Muruganandam, AV | 1 |
| Battaglia, A; Canonico, PL; Francioli, E; Lombardi, G; Miglio, G; Varsaldi, F | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Del Bel, EA; Lazzarini, M; Salum, C | 1 |
| Gursoy, B; Kirli, S; Sarandöl, E; Sipahioglu, D; Sivrioglu, EY | 1 |
| Kasture, AS; Kasture, SB; Mohan, M; Pathan, AA | 1 |
| An, HM; Kosten, TR; Li, J; Shi, J; Tan, YL; Wang, YC; Wang, ZR; Yang, FD; Zhang, XY; Zhou, DF | 1 |
| Bošković, M; Grabnar, I; Koprivšek, J; Plesničar, BK; Vovk, T | 1 |
| An, HM; Kosten, TR; Li, J; Lv, MH; Shi, J; Soares, JC; Tan, YL; Wang, YC; Wang, ZR; Yang, FD; Zhang, XY; Zhou, DF | 1 |
| An, HM; Li, J; Lv, MH; Shi, J; Soares, JC; Tan, YL; Wang, YC; Wang, ZR; Wu, JQ; Yan, SX; Yang, FD; Zhang, XY | 1 |
| An, HM; Lv, MH; Shi, J; Soares, JC; Tan, YL; Wang, Z; Yang, F; Zhang, XY; Zhou, D | 1 |
2 review(s) available for d-alpha tocopherol and haloperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
3 trial(s) available for d-alpha tocopherol and haloperidol
| Article | Year |
|---|---|
Haloperidol-induced extrapyramidal reaction: lack of protective effect by vitamin E.
Topics: Adolescent; Adult; Antioxidants; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Haloperidol; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Time Factors; Vitamin E | 1998 |
The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antioxidants; Antipsychotic Agents; Ascorbic Acid; Erythrocytes; Fatty Acids, Omega-3; Female; Haloperidol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Pilot Projects; Schizophrenia; Schizophrenic Psychology; Superoxide Dismutase; Treatment Outcome; Vitamin E | 2007 |
Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol.
Topics: Administration, Oral; Adult; Antioxidants; Antipsychotic Agents; Biomarkers; Combined Modality Therapy; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dietary Supplements; Double-Blind Method; Fatty Acids, Essential; Fatty Acids, Omega-3; Haloperidol; Humans; Male; Middle Aged; Oleic Acid; Oxidative Stress; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Vitamin E | 2016 |
20 other study(ies) available for d-alpha tocopherol and haloperidol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of chronic haloperidol on vitamin E levels and monoamine metabolism in rats fed normal and vitamin E deficient diets.
Topics: Animals; Biogenic Monoamines; Corpus Striatum; Dopamine; Female; Haloperidol; Male; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra; Time Factors; Vitamin E; Vitamin E Deficiency | 1990 |
Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Basal Ganglia Diseases; Benztropine; Chronic Disease; Cognition; Drug Therapy, Combination; Glycine; Haloperidol; Humans; Loxapine; Male; Pilot Projects; Schizophrenia; Thiothixene; Vitamin E | 1989 |
[Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia].
Topics: Adolescent; Adult; Aged; alpha-Tocopherol; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chronic Disease; Compulsive Personality Disorder; Drug Evaluation; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Niacinamide; Personality Disorders; Psychopathology; Pyridoxal Phosphate; Schizophrenia; Tocopherols; Vitamin E | 1988 |
[Effect of pharmacological substances on the altered permeability of the hemato-encephalic barrier for 14C-tyrosine due to ethanol].
Topics: Alcoholism; Animals; Blood-Brain Barrier; Carbon Radioisotopes; Cell Membrane Permeability; Chlorpromazine; Dose-Response Relationship, Drug; Ethanol; Haloperidol; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Tyrosine; Vitamin E | 1987 |
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dyskinesia, Drug-Induced; Grooming; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin E | 1993 |
Haloperidol-induced cell death--mechanism and protection with vitamin E in vitro.
Topics: Animals; Antipsychotic Agents; Apoptosis; Cell Death; Cricetinae; Cricetulus; Dopamine Antagonists; Glioma; Haloperidol; Hippocampus; Hybrid Cells; Mice; Necrosis; Neurons; Neuroprotective Agents; Tumor Cells, Cultured; Vitamin E | 1995 |
Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.
Topics: Animals; Antioxidants; Cell Survival; Clone Cells; Dopamine Antagonists; Gene Expression Regulation; Glutathione; Haloperidol; Hippocampus; Melatonin; Mice; Neurons; Neuroprotective Agents; Neurotoxins; NF-kappa B; Oxidative Stress; Peroxides; Serotonin; Transcriptional Activation; Vitamin E | 1998 |
Vitamin E and other antioxidants in neuroprotection.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Estrogens; Female; Free Radical Scavengers; Haloperidol; Humans; Male; Nerve Degeneration; Neurodegenerative Diseases; Neurons; NF-kappa B; Oxidative Stress; Signal Transduction; Vitamin E | 1999 |
Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia.
Topics: Acetylcysteine; Animals; Antipsychotic Agents; Apoptosis; Brain; Cell Survival; Cells, Cultured; Dyskinesia, Drug-Induced; Embryo, Mammalian; Free Radical Scavengers; Haloperidol; Mice; Mice, Inbred ICR; Neurons; PC12 Cells; Rats; Vitamin E | 2000 |
Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity.
Topics: alpha-Tocopherol; Animals; Antioxidants; Antipsychotic Agents; Apoptosis; Cell Line; Haloperidol; Hippocampus; Male; Mice; Motor Activity; Neurotoxins; NF-kappa B; Oxidative Stress; Protective Agents; Rats; Rats, Wistar | 2002 |
Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Disease Models, Animal; Dyskinesia, Drug-Induced; Ergosterol; Glycosides; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Sitosterols; Solanaceae; Valproic Acid; Vitamin E; Withanolides | 2002 |
Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Euphorbiaceae; GABA Modulators; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Tannins; Valproic Acid; Vitamin E | 2000 |
Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia.
Topics: Animals; Antioxidants; Cabergoline; Cell Death; Cell Hypoxia; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ergolines; Free Radical Scavengers; Free Radicals; Gene Expression; Genes, bcl-2; Glucose; Haloperidol; Humans; Ischemia; Neurons; Thiobarbituric Acid Reactive Substances; Time Factors; Tretinoin; Vitamin E | 2004 |
Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Enzyme Inhibitors; Haloperidol; Indazoles; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Time Factors; Vitamins | 2005 |
Mucuna pruriens attenuates haloperidol-induced orofacial dyskinesia in rats.
Topics: Akathisia, Drug-Induced; Animals; Antioxidants; Free Radicals; Haloperidol; Male; Mucuna; Plant Extracts; Rats; Rats, Wistar; Vitamin E | 2011 |
Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Free Radical Scavengers; Ginkgo biloba; Haloperidol; Male; Mastication; Plant Extracts; Rats; Rats, Sprague-Dawley; Vitamin E | 2013 |
Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.
Topics: Animals; Anti-Dyskinesia Agents; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Ginkgo biloba; Haloperidol; Immunohistochemistry; Injections, Intraperitoneal; Male; Mastication; Movement Disorders; Plant Extracts; Random Allocation; Rats, Sprague-Dawley; S100 Calcium Binding Protein beta Subunit; Vitamin E | 2016 |
Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Corpus Striatum; Disease Models, Animal; Ginkgo biloba; Haloperidol; Male; Mastication; Plant Extracts; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tardive Dyskinesia; Vitamin E | 2016 |
Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.
Topics: alpha-Tocopherol; Animals; Antioxidants; Antipsychotic Agents; bcl-2-Associated X Protein; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Ginkgo biloba; Haloperidol; Injections, Intraperitoneal; Male; Mastication; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley | 2016 |